Serum Aluminium Levels in Stage 4, 5 & 5D Chronic Kidney Disease

Journal Title: International Journal of Medical Research Professionals - Year 2017, Vol 3, Issue 4

Abstract

Objectives: Use of non aluminum containing phosphate binders and improvement in feed water quality for hemodialysis (HD) have resulted in low prevalence of aluminum toxicity. The study was undertaken to detect the prevalence of high serum Al levels in chronic kidney disease (CKD) patients & controls. Settings & Design: Cross sectional study carried out at a tertiary care teaching hospital. Methods: We analyzed the serum aluminum levels in 32 CKD patients & 32 controls. It was one time sample check. The levels were correlated with anemia, Serum PTH levels, neurologic features if any. Iron status was noted in all. Results: All 32 CKD patients were anemic with Hb levels between 7 to 10 gm%. None were on any medication containing aluminum. Al level in our institute tap water & R.O. Water was < 5μg/l. Six volunteers showed Serum Al level range between 5 to15 μg/l while it was undetectable in remaining 26 volunteers. All 32 CKD patients had Serum Al > 5μg/l: 23 with 5 to 40 μg/l, 8 with 40 to 200 μg/l & one > 200 μg/l. Of 23 pts [in range 5 to 40 μg/l], 19 were on Maintenance HD while 4 were pre –HD. All 8 patients [in range 40 to 200 μg/l] & the one with S.Al > 200 μg/l were on HD. The difference in serum aluminium levels in two groups [Control Vs CKD] was significant (p< 0.001). The co-relation between serum Al level and Calcium (p- 0.21), as well as iPTH (p- 0.42) were not significant. None had any neurologic features. Conclusions: Serum aluminum was detectable in only 23% of controls but 100% in CKD patients. Though detectable, the levels were not significant in controls. However, 28% of CKD had S.Al >40 μg/l. Though it is a small study group, it highlights significantly higher levels, the source of which needs to be looked into.

Authors and Affiliations

Sandip P. Bhurke, Kalpana S. Mehta, Rudramani Swami, Amol Bhagat, Atim Pajai

Keywords

Related Articles

Early Development of Overt Proteinuria in Extremely Uncontrolled Type 1 Diabetic Patients

Introduction: Overt proteinuria usually occurs in 15 to 40% of patients with type1 diabetes, with a peak incidence around 15 to 20 years of diabetes. The aim of the study is to know the incidence of overt proteinuria in...

Evaluation of Complications in Patients Undergoing Treatment for Femoral Shaft Fractures with Undreamed Intramedullary Nailing

Background: Fracture of the shaft of femur is a commonly seen fracture in orthopedic practice, and it is frequently associated with injuries to other sites. The aim of the present study is to evaluate the Complications i...

Serum Homocysteine Levels in Non-Alcoholic Fatty Liver Disease Patients At Tertiary Care Hospital at Uttarakhand

Background: Non-alcoholic fatty liver disease (NAFLD) is a common disorder which causes serum liver enzyme elevation. Elevated homocysteine levels were demonstrated in fatty liver disease and chronic liver failure. Howev...

Inter-Generational Variation of Nasal Morphology of Meitei Males of Manipur, India

Introduction: In the present era of knowledge, study of Nasal Morphology is one such area which contributes theoretically in the understanding of human biological evolutionary process of human face on one hand, and clini...

A Rare Case of Acromegaly Among Yamani Male

Acromegaly is a rare disease caused by an over growth hormone secretion, mostly as a result of pituitary adenoma. A 30 year old Yamni male presented with increased stature growth and excessive enlargement of feet and han...

Download PDF file
  • EP ID EP546849
  • DOI 10.21276/ijmrp.2017.3.4.038
  • Views 91
  • Downloads 0

How To Cite

Sandip P. Bhurke, Kalpana S. Mehta, Rudramani Swami, Amol Bhagat, Atim Pajai (2017). Serum Aluminium Levels in Stage 4, 5 & 5D Chronic Kidney Disease. International Journal of Medical Research Professionals, 3(4), 178-183. https://europub.co.uk/articles/-A-546849